Evolent Health, Inc. Quarterly Depreciation in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Evolent Health, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q3 2024.
  • Evolent Health, Inc. Depreciation for the quarter ending September 30, 2024 was $7.5M, a 11.8% decline year-over-year.
  • Evolent Health, Inc. Depreciation for the twelve months ending September 30, 2024 was $30.5M, a 9.5% decline year-over-year.
  • Evolent Health, Inc. annual Depreciation for 2023 was $32.4M, a 1.25% increase from 2022.
  • Evolent Health, Inc. annual Depreciation for 2022 was $32M, a 4.58% increase from 2021.
  • Evolent Health, Inc. annual Depreciation for 2021 was $30.6M, a 8.13% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $30.5M $7.5M -$1M -11.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $31.5M $7.9M -$300K -3.66% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $31.8M $7.5M -$600K -7.41% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $32.4M $7.6M -$1.3M -14.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $33.7M $8.5M +$800K +10.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $32.9M $8.2M +$400K +5.13% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $32.5M $8.1M +$500K +6.58% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $32M $8.9M +$1.1M +14.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $30.9M $7.7M +$300K +4.05% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $30.6M $7.8M +$200K +2.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $30.4M $7.6M -$200K -2.56% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $30.6M $7.8M +$700K +9.86% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $29.9M $7.4M +$100K +1.37% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $29.8M $7.6M +$500K +7.04% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $29.3M $7.8M +$1M +14.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $28.3M $7.1M +$700K +10.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $27.6M $7.3M +$1.3M +21.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $26.3M $7.1M +$1.4M +24.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $24.9M $6.8M +$1.6M +30.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $23.3M $6.4M +$900K +16.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $22.4M $6M +$1.7M +39.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $20.7M $5.7M +$1.8M +46.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $18.9M $5.2M +$1.6M +44.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q4 2018 $17.3M $5.5M +$2.3M +71.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $15M $4.3M +$2M +87% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $13M $3.9M +$2M +105% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $11M $3.6M +$1.8M +100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $9.2M $3.2M +$3M +1500% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $6.2M $2.3M +$1.4M +156% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $4.8M $1.9M +$1.1M +138% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $3.7M $1.8M +$1.1M +157% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.6M $200K -$300K -60% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $2.9M $900K +$400K +80% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $2.5M $800K +$600K +300% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $1.9M $700K +$700K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.2M $500K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $500K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $200K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.